110 related articles for article (PubMed ID: 25159093)
21. miR-320a suppresses colorectal cancer progression by targeting Rac1.
Zhao H; Dong T; Zhou H; Wang L; Huang A; Feng B; Quan Y; Jin R; Zhang W; Sun J; Zhang D; Zheng M
Carcinogenesis; 2014 Apr; 35(4):886-95. PubMed ID: 24265291
[TBL] [Abstract][Full Text] [Related]
22. MiR-320a contributes to atherogenesis by augmenting multiple risk factors and down-regulating SRF.
Chen C; Wang Y; Yang S; Li H; Zhao G; Wang F; Yang L; Wang DW
J Cell Mol Med; 2015 May; 19(5):970-85. PubMed ID: 25728840
[TBL] [Abstract][Full Text] [Related]
23. miR-320a regulates cell proliferation and apoptosis in multiple myeloma by targeting pre-B-cell leukemia transcription factor 3.
Lu Y; Wu D; Wang J; Li Y; Chai X; Kang Q
Biochem Biophys Res Commun; 2016 May; 473(4):1315-1320. PubMed ID: 27086852
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1.
Yang G; Wu D; Zhu J; Jiang O; Shi Q; Tian J; Weng Y
Oncol Rep; 2013 Aug; 30(2):877-89. PubMed ID: 23760062
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly.
Zhang X; Huang L; Zhao Y; Tan W
Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):995-1001. PubMed ID: 24145606
[TBL] [Abstract][Full Text] [Related]
26. MiR-320a downregulation is associated with imatinib resistance in gastrointestinal stromal tumors.
Gao X; Shen K; Wang C; Ling J; Wang H; Fang Y; Shi Y; Hou Y; Qin J; Sun Y; Qin X
Acta Biochim Biophys Sin (Shanghai); 2014 Jan; 46(1):72-5. PubMed ID: 24217767
[TBL] [Abstract][Full Text] [Related]
27. Elevated expression of TrpC5 and GLUT1 is associated with chemoresistance in colorectal cancer.
Wang T; Ning K; Lu TX; Hua D
Oncol Rep; 2017 Feb; 37(2):1059-1065. PubMed ID: 28000878
[TBL] [Abstract][Full Text] [Related]
28. miR-320a regulates erythroid differentiation through MAR binding protein SMAR1.
Mittal SP; Mathai J; Kulkarni AP; Pal JK; Chattopadhyay S
Int J Biochem Cell Biol; 2013 Nov; 45(11):2519-29. PubMed ID: 23876508
[TBL] [Abstract][Full Text] [Related]
29. Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma.
Moriya Y; Nohata N; Kinoshita T; Mutallip M; Okamoto T; Yoshida S; Suzuki M; Yoshino I; Seki N
J Hum Genet; 2012 Jan; 57(1):38-45. PubMed ID: 22089643
[TBL] [Abstract][Full Text] [Related]
30. Aberrant DNA methylation of miR-219 promoter in long-term night shiftworkers.
Shi F; Chen X; Fu A; Hansen J; Stevens R; Tjonneland A; Vogel UB; Zheng T; Zhu Y
Environ Mol Mutagen; 2013 Jul; 54(6):406-13. PubMed ID: 23813567
[TBL] [Abstract][Full Text] [Related]
31. Transient receptor potential channel TRPC5 is essential for P-glycoprotein induction in drug-resistant cancer cells.
Ma X; Cai Y; He D; Zou C; Zhang P; Lo CY; Xu Z; Chan FL; Yu S; Chen Y; Zhu R; Lei J; Jin J; Yao X
Proc Natl Acad Sci U S A; 2012 Oct; 109(40):16282-7. PubMed ID: 22988121
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2.
Liang L; Li X; Zhang X; Lv Z; He G; Zhao W; Ren X; Li Y; Bian X; Liao W; Liu W; Yang G; Ding Y
Gastroenterology; 2013 Mar; 144(3):624-635.e4. PubMed ID: 23201162
[TBL] [Abstract][Full Text] [Related]
33. miR-206 is down-regulated in breast cancer and inhibits cell proliferation through the up-regulation of cyclinD2.
Zhou J; Tian Y; Li J; Lu B; Sun M; Zou Y; Kong R; Luo Y; Shi Y; Wang K; Ji G
Biochem Biophys Res Commun; 2013 Apr; 433(2):207-12. PubMed ID: 23466356
[TBL] [Abstract][Full Text] [Related]
34. Essential role for TrpC5-containing extracellular vesicles in breast cancer with chemotherapeutic resistance.
Ma X; Chen Z; Hua D; He D; Wang L; Zhang P; Wang J; Cai Y; Gao C; Zhang X; Zhang F; Wang T; Hong T; Jin L; Qi X; Chen S; Gu X; Yang D; Pan Q; Zhu Y; Chen Y; Chen D; Jiang L; Han X; Zhang Y; Jin J; Yao X
Proc Natl Acad Sci U S A; 2014 Apr; 111(17):6389-94. PubMed ID: 24733904
[TBL] [Abstract][Full Text] [Related]
35. Mechanical compression induces VEGFA overexpression in breast cancer via DNMT3A-dependent miR-9 downregulation.
Kim BG; Gao MQ; Kang S; Choi YP; Lee JH; Kim JE; Han HH; Mun SG; Cho NH
Cell Death Dis; 2017 Mar; 8(3):e2646. PubMed ID: 28252641
[TBL] [Abstract][Full Text] [Related]
36. Increasing circulating exosomes-carrying TRPC5 predicts chemoresistance in metastatic breast cancer patients.
Wang T; Ning K; Lu TX; Sun X; Jin L; Qi X; Jin J; Hua D
Cancer Sci; 2017 Mar; 108(3):448-454. PubMed ID: 28032400
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA miR-320a and miR-140 inhibit mink enteritis virus infection by repression of its receptor, feline transferrin receptor.
Sun JZ; Wang J; Wang S; Yuan D; Li Z; Yi B; Hou Q; Mao Y; Liu W
Virol J; 2014 Dec; 11():210. PubMed ID: 25465595
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-214 regulates immunity-related genes in bovine mammary epithelial cells by targeting NFATc3 and TRAF3.
Song N; Wang X; Gui L; Raza SHA; Luoreng Z; Zan L
Mol Cell Probes; 2017 Oct; 35():27-33. PubMed ID: 28627449
[TBL] [Abstract][Full Text] [Related]
39. Transient receptor potential channel C5 in cancer chemoresistance.
He DX; Ma X
Acta Pharmacol Sin; 2016 Jan; 37(1):19-24. PubMed ID: 26657058
[TBL] [Abstract][Full Text] [Related]
40. Delivery of miR-320a-3p by gold nanoparticles combined with photothermal therapy for directly targeting Sp1 in lung cancer.
Peng J; Wang R; Sun W; Huang M; Wang R; Li Y; Wang P; Sun G; Xie S
Biomater Sci; 2021 Sep; 9(19):6528-6541. PubMed ID: 34582541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
